IL27 and neoplasm: IL-27 therapy inhibited the growth of NK-resistant head and neck squamous carcinoma cells in syngeneic mice through the induction of an anti-tumor IgG antibody response and NK-mediated antibody-dependent cellular cytotoxicity [36].